Group 1 - The core point of the article is that Maipu Medical (301033) is in the process of acquiring 100% equity of Yijie Medical through a combination of issuing shares and cash payment, which constitutes a related party transaction [1][3] - As of September 3, 2025, Maipu Medical's stock closed at 75.18 yuan, down 1.12%, with a turnover rate of 2.13% and a trading volume of 11,900 shares, resulting in a transaction amount of 90.23 million yuan [1] - On September 3, 2025, the net outflow of main funds was 5.56 million yuan, while retail investors saw a net inflow of 8.42 million yuan [1][3] Group 2 - The company announced that the transaction is not expected to constitute a major asset reorganization but is classified as a related party transaction, which does not lead to a restructuring listing [1] - The company has been in a trading suspension since May 22, 2025, and resumed trading on June 6, 2025, when it disclosed the restructuring plan [1] - As of the date of the announcement, intermediary institutions are conducting due diligence, auditing, and evaluation, which have not yet been completed [1]
股市必读：迈普医学（301033）9月3日主力资金净流出555.99万元